Literature DB >> 31589125

Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases.

Martyna Godzieba1, Slawomir Ciesielski1.   

Abstract

Cancer and infectious diseases are one of the greatest challenges of modern medicine. An unhealthy lifestyle, the improper use of drugs, or their abuse are conducive to the increase of morbidity and mortality caused by these diseases. The imperfections of drugs currently used in therapy for these diseases and the increasing problem of drug resistance have forced a search for new substances with therapeutic potential. Throughout history, plants, animals, fungi and microorganisms have been rich sources of biologically active compounds. Even today, despite the development of chemistry and the introduction of many synthetic chemotherapeutics, a substantial part of the new compounds being tested for treatment are still of natural origin. Natural compounds exhibit a great diversity of chemical structures, and thus possess diverse mechanisms of action and molecular targets. Nucleic acids seem to be a good molecular target for substances with anticancer potential in particular, but they may also be a target for antimicrobial compounds. There are many types of interactions of small-molecule ligands with DNA. This publication focuses on the intercalation process. Intercalators are compounds that usually have planar aromatic moieties and can insert themselves between adjacent base pairs in the DNA helix. These types of interactions change the structure of DNA, leading to various types of disorders in the functioning of cells and the cell cycle. This article presents the most promising intercalators of natural origin, which have aroused interest in recent years due to their therapeutic potential. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  DNA binding; Intercalators; alkylating compounds; anticancer; antimicrobial; drugs.

Mesh:

Substances:

Year:  2020        PMID: 31589125     DOI: 10.2174/1568009619666191007112516

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  5 in total

1.  fingeRNAt-A novel tool for high-throughput analysis of nucleic acid-ligand interactions.

Authors:  Natalia A Szulc; Zuzanna Mackiewicz; Janusz M Bujnicki; Filip Stefaniak
Journal:  PLoS Comput Biol       Date:  2022-06-02       Impact factor: 4.779

Review 2.  Functional DNA-Polymer Conjugates.

Authors:  Colette J Whitfield; Meizhou Zhang; Pia Winterwerber; Yuzhou Wu; David Y W Ng; Tanja Weil
Journal:  Chem Rev       Date:  2021-03-19       Impact factor: 60.622

Review 3.  Pharmacological Modulation of Steroid Activity in Hormone-Dependent Breast and Prostate Cancers: Effect of Some Plant Extract Derivatives.

Authors:  Bagora Bayala; Abdou Azaque Zoure; Silvère Baron; Cyrille de Joussineau; Jacques Simpore; Jean-Marc A Lobaccaro
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

Review 4.  Drug Combination in Cancer Treatment-From Cocktails to Conjugated Combinations.

Authors:  Yosi Gilad; Gary Gellerman; David M Lonard; Bert W O'Malley
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

5.  Electrochemical investigations of DNA-Intercalation potency of bisnitrophenoxy compounds with different alkyl chain lengths.

Authors:  Maria Shakeel; Tehmeena Maryum Butt; Maria Zubair; Humaira Masood Siddiqi; Naveed Kauser Janjua; Zareen Akhter; Azra Yaqub; Sadia Mahmood
Journal:  Heliyon       Date:  2020-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.